Quoin Pharmaceuticals, Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QNRX research report →
Companyquoinpharma.com
Quoin Pharmaceuticals, Ltd. , a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome.
- CEO
- Michael Myers
- IPO
- 2016
- Employees
- 3
- HQ
- Ashburn, VA, US
Price Chart
Valuation
- Market Cap
- $2.91M
- P/E
- -0.57
- P/S
- 0.00
- P/B
- 1.10
- EV/EBITDA
- 0.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -292.33%
- ROIC
- -168.66%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-15,804,655 · -76.34%
- EPS
- $-10.63 · 84.10%
- Op Income
- $-16,290,716
- FCF YoY
- -172236.28%
Performance & Tape
- 52W High
- $41.80
- 52W Low
- $4.81
- 50D MA
- $6.64
- 200D MA
- $9.66
- Beta
- 1.62
- Avg Volume
- 96.57K
Get TickerSpark's AI analysis on QNRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 26, 26 | Stonepine Capital Management, LLC | other | 0 |
| Feb 4, 26 | Lawlor Sally Bridget | other | 85,250 |
| Feb 4, 26 | Cooper Joseph Patrick | other | 8,141 |
| Feb 4, 26 | Culverwell Anthony James | other | 21,709 |
| Feb 4, 26 | Myers Michael | other | 318,750 |
| Feb 4, 26 | Carter Denise P. | other | 318,750 |
| Feb 4, 26 | LANGER DENNIS | other | 21,709 |
| Feb 4, 26 | SEMBER MICHAEL T | other | 8,141 |
| Feb 4, 26 | Leong Natalie Ee Mun | other | 12,211 |
| Jan 29, 26 | Stonepine Capital Management, LLC | other | 0 |
Our QNRX Coverage
We haven't published any research on QNRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QNRX Report →